Theravance Biopharma,. Stock Forecast
Recent Theravance Biopharma,. Stock Price |
|
Theravance Biopharma,. Stock Forecast Price |
$9.12 |
+80.92% |
$16.50 |
As of 2024-04-29
Recent Theravance Biopharma,. Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
3 |
2 |
2 |
2 |
Buy ratings: |
0 |
0 |
0 |
0 |
Hold ratings: |
2 |
2 |
2 |
2 |
Sell ratings: |
0 |
0 |
0 |
0 |
Strong sell ratings: |
0 |
0 |
0 |
0 |
Average rating: |
1.8 |
2.0 |
2.0 |
2.0 |
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
The presented Theravance Biopharma,. stock forecast (traded under symbol TBPH), for forward-twelve-months price target as shown at the top of this page, gives you the average Theravance Biopharma,. stock forecast for forward target price for symbol TBPH, across the 4 analysts covering Theravance Biopharma,. (TBPH), as reported in
data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Theravance Biopharma,. stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Theravance Biopharma,. stock forecast and half had a lower Theravance Biopharma,. stock forecast) was $17.5 as of 2024-04-29 (which is a different mathematical metric versus taking the average or mean), while the
highest Theravance Biopharma,. stock forecast in the analyst group was $21.0, and the lowest Theravance Biopharma,. stock forecast in the analyst group was
$10.0, with a standard deviation of $5.066. Get the latest Zacks research report on TBPH — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
Company Name: |
Theravance Biopharma, Inc. |
Website: |
www.theravance.com |
Sector: |
Biotechnology |
Number of ETFs Holding TBPH: |
28 |
Total Market Value Held by ETFs: |
$43.31M |
Total Market Capitalization: |
$442.00M |
% of Market Cap. Held by ETFs: |
9.80% |
|
|
April 29, 2024 10:17 AM Eastern
Buy (3.20 out of 4)
39th percentile
|
|